| Ms Terren Courtney Wortham, DNP, CRNA | |
|
18701 N 67th Ave, Glendale, AZ 85308-7100 | |
| (623) 561-1000 | |
| Not Available |
| Full Name | Ms Terren Courtney Wortham |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 18701 N 67th Ave, Glendale, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043795370 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 95000998 (California) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 265258 (Arizona) | Primary |
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
BioCryst Pharmaceuticals, Inc. announced it is initiating a Phase 2 study of BCX4208 alone and in combination with allopurinol in patients with gout. BioCryst recently reported positive results from part one of its Phase 2 monotherapy study of BCX4208 in patients with gout and is now moving forward as planned with an additional Phase 2 trial of BCX4208.
The Keck School of Medicine of the University of Southern California has announced a $24 million charitable gift from media executive and philanthropist Sumner M. Redstone. The multi-million dollar gift will support cancer research directed by renowned oncologist David Agus, M.D., professor of medicine at the Keck School of Medicine of USC and director of the USC Center for Applied Molecular Medicine and the USC Westside Prostate Cancer Center.
Thousands of studies take place every year in healthcare settings. A report published recently in the American Journal of Preventative Medicine describes how to do many of these studies more rapidly.
Using T cells primed for the infectious disease toxoplasmosis, Whitehead Institute researchers have created novel mouse models of the immune system that more accurately reflect how immune cells actually respond to pathogens in their presence.
› Verified 9 days ago
| Entity Name | Regents Of The Univ Of Ca |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013906973 PECOS PAC ID: 3375456619 Enrollment ID: O20031111000892 |
News Archive
BioCryst Pharmaceuticals, Inc. announced it is initiating a Phase 2 study of BCX4208 alone and in combination with allopurinol in patients with gout. BioCryst recently reported positive results from part one of its Phase 2 monotherapy study of BCX4208 in patients with gout and is now moving forward as planned with an additional Phase 2 trial of BCX4208.
The Keck School of Medicine of the University of Southern California has announced a $24 million charitable gift from media executive and philanthropist Sumner M. Redstone. The multi-million dollar gift will support cancer research directed by renowned oncologist David Agus, M.D., professor of medicine at the Keck School of Medicine of USC and director of the USC Center for Applied Molecular Medicine and the USC Westside Prostate Cancer Center.
Thousands of studies take place every year in healthcare settings. A report published recently in the American Journal of Preventative Medicine describes how to do many of these studies more rapidly.
Using T cells primed for the infectious disease toxoplasmosis, Whitehead Institute researchers have created novel mouse models of the immune system that more accurately reflect how immune cells actually respond to pathogens in their presence.
› Verified 9 days ago
| Entity Name | Anesthesia Services Of San Joaquin Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366778227 PECOS PAC ID: 4082754056 Enrollment ID: O20091223000174 |
News Archive
BioCryst Pharmaceuticals, Inc. announced it is initiating a Phase 2 study of BCX4208 alone and in combination with allopurinol in patients with gout. BioCryst recently reported positive results from part one of its Phase 2 monotherapy study of BCX4208 in patients with gout and is now moving forward as planned with an additional Phase 2 trial of BCX4208.
The Keck School of Medicine of the University of Southern California has announced a $24 million charitable gift from media executive and philanthropist Sumner M. Redstone. The multi-million dollar gift will support cancer research directed by renowned oncologist David Agus, M.D., professor of medicine at the Keck School of Medicine of USC and director of the USC Center for Applied Molecular Medicine and the USC Westside Prostate Cancer Center.
Thousands of studies take place every year in healthcare settings. A report published recently in the American Journal of Preventative Medicine describes how to do many of these studies more rapidly.
Using T cells primed for the infectious disease toxoplasmosis, Whitehead Institute researchers have created novel mouse models of the immune system that more accurately reflect how immune cells actually respond to pathogens in their presence.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Terren Courtney Wortham, DNP, CRNA 17685 W Golden Eye Ave, Goodyear, AZ 85338-5847 Ph: (623) 217-7005 | Ms Terren Courtney Wortham, DNP, CRNA 18701 N 67th Ave, Glendale, AZ 85308-7100 Ph: (623) 561-1000 |
News Archive
BioCryst Pharmaceuticals, Inc. announced it is initiating a Phase 2 study of BCX4208 alone and in combination with allopurinol in patients with gout. BioCryst recently reported positive results from part one of its Phase 2 monotherapy study of BCX4208 in patients with gout and is now moving forward as planned with an additional Phase 2 trial of BCX4208.
The Keck School of Medicine of the University of Southern California has announced a $24 million charitable gift from media executive and philanthropist Sumner M. Redstone. The multi-million dollar gift will support cancer research directed by renowned oncologist David Agus, M.D., professor of medicine at the Keck School of Medicine of USC and director of the USC Center for Applied Molecular Medicine and the USC Westside Prostate Cancer Center.
Thousands of studies take place every year in healthcare settings. A report published recently in the American Journal of Preventative Medicine describes how to do many of these studies more rapidly.
Using T cells primed for the infectious disease toxoplasmosis, Whitehead Institute researchers have created novel mouse models of the immune system that more accurately reflect how immune cells actually respond to pathogens in their presence.
› Verified 9 days ago
Juan N Aliaga, DNP, APRN-CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 18701 N 67th Ave, Glendale, AZ 85308 Phone: 623-561-1000 | |
Jason Scott Herndon, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 18701 N 67th Ave, Glendale, AZ 85308 Phone: 623-561-1000 | |
Camarae Mikaela Mather, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 18701 N 67th Ave, Glendale, AZ 85308 Phone: 602-653-3012 | |
Stephen Patrick Standish, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5901 W Behrend Dr Apt 1155, Glendale, AZ 85308 Phone: 206-372-7032 | |
Kenneth Michael Bania, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 18701 N 67th Ave, Glendale, AZ 85308 Phone: 623-561-1000 | |
Aaron Morrow, PHARMD Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 19410 N 68th Ave, Glendale, AZ 85308 Phone: 505-710-6292 |